Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px
Document › Details

Voluntis S.A.. (11/23/20). "Press Release: Voluntis Successfully Completes a Capital Increase of €5.9 Million and Finalizes the Financing of Its Strategic Roadmap [Not for US, CA, AU or JP] Japan.". Cambridge, MA & Paris.

Organisations Organisation Voluntis S.A. (Euronext Paris: VTX)
  Group Voluntis (Group)
  Organisation 2 Debiopharm Innovation Fund S.A.
  Group Debiopharm (Group)
Products Product digital health
  Product 2 venture capital
Index term Index term Voluntis–SEVERAL: investment, 202011 capital increase €5.93m net €5.7m led by Debiopharm Innovation Fund
Persons Person Leurent, Pierre (Voluntis 201805 CEO + Co-Founder)
  Person 2 Dowe, Tanja (Debiopharm 201705 Head of Debiopharm Innovation Fund)

Record changed: 2020-11-30


Picture [iito] Plain Stupid Simple 650x80px

More documents for Voluntis (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80

» top